Strategic Wealth Partners Ltd. lowered its stake in Cigna Corp (NYSE:CI) by 20.9% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 261 shares of the health services provider’s stock after selling 69 shares during the period. Strategic Wealth Partners Ltd.’s holdings in Cigna were worth $41,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of CI. TRUE Private Wealth Advisors purchased a new stake in shares of Cigna in the 2nd quarter worth approximately $40,000. Prime Capital Investment Advisors LLC boosted its stake in Cigna by 32.5% during the 2nd quarter. Prime Capital Investment Advisors LLC now owns 257 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 63 shares during the last quarter. Trustcore Financial Services LLC purchased a new stake in Cigna during the 1st quarter valued at $49,000. Close Asset Management Ltd purchased a new stake in Cigna during the 1st quarter valued at $55,000. Finally, Rational Advisors LLC purchased a new stake in Cigna during the 1st quarter valued at $61,000. Institutional investors own 87.64% of the company’s stock.
Several brokerages have commented on CI. Goldman Sachs Group downgraded Cigna from a “conviction-buy” rating to a “buy” rating in a research note on Friday, May 3rd. Zacks Investment Research downgraded Cigna from a “buy” rating to a “hold” rating and set a $164.00 target price on the stock. in a research note on Tuesday, June 11th. ValuEngine downgraded Cigna from a “hold” rating to a “sell” rating in a research note on Tuesday, July 23rd. Morgan Stanley cut their target price on Cigna from $241.00 to $207.00 and set an “overweight” rating on the stock in a research note on Friday, July 12th. Finally, Raymond James increased their target price on Cigna from $185.00 to $190.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the company. Cigna currently has a consensus rating of “Buy” and an average price target of $214.55.
Cigna (NYSE:CI) last released its quarterly earnings results on Thursday, August 1st. The health services provider reported $4.30 earnings per share for the quarter, beating the consensus estimate of $3.74 by $0.56. The firm had revenue of $34.38 billion for the quarter, compared to analysts’ expectations of $33.27 billion. Cigna had a return on equity of 13.24% and a net margin of 3.60%. The company’s revenue was up 198.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.89 EPS. Equities analysts forecast that Cigna Corp will post 16.75 earnings per share for the current fiscal year.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Story: How accurate is the Rule of 72?
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.